Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 77 are a BUY (77%), 17 are a HOLD (17%), 6 are a SELL (6%).
Analyst Whitney Ijem, currently employed at CANACCORD, carries an average stock price target met ratio of 30.8% that have a potential upside of 23.87% achieved within 219 days.
Whitney Ijem’s has documented 198 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TSHA, Taysha Gene Therapies at 16-May-2025.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$84
$46.4 (123.40%)
$175
15 days ago
(20-May-2025)
9/17 (52.94%)
$44.01 (110.05%)
125
Buy
$50
$12.4 (32.98%)
$217
27 days ago
(08-May-2025)
6/12 (50%)
$13.48 (36.91%)
212
Buy
$125
$87.4 (232.45%)
$183
28 days ago
(07-May-2025)
11/31 (35.48%)
$88.28 (240.41%)
349
Hold
$58
$20.4 (54.26%)
$87
28 days ago
(07-May-2025)
16/51 (31.37%)
$21.28 (57.95%)
337
Buy
$113
$75.4 (200.53%)
$182
28 days ago
(07-May-2025)
17/28 (60.71%)
$76.28 (207.73%)
294
Which stock is Whitney Ijem is most bullish on?
Which stock is Whitney Ijem is most reserved on?
What Year was the first public recommendation made by Whitney Ijem?